Oncopeptides AB (publ)
ONCO
Rank in Stocks
#20709
Oncopeptides AB (publ) is a biotechnology firm dedicated to developing medical... Oncopeptides AB (publ) is a biotechnology firm dedicated to developing medical therapies for cancer, serving markets across the United States, Europe, and worldwide. Its foremost experimental compound, melflufen, is a distinct peptide-drug conjugate engineered to address multiple myeloma that has relapsed or become resistant to prior treatments in adult individuals. Founded in 2000, Oncopeptides AB (publ) conducts its main business from Stockholm, Sweden.
Share Price
$0.18527947
Last synced: 2026-11-09
Market Cap
$79.92M
Change (1 day)
5.09%
Change (1 year)
-65.67%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Oncopeptides AB (publ) (ONCO)
Category
Healthcare
EPS for Oncopeptides AB (publ) (ONCO)
EPS as of June 2026 TTM: $-0.08
According to Oncopeptides AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.08. At the end of 2025 the company had an EPS of $-0.12, an increase over its 2024 EPS of $-0.16.
EPS history for Oncopeptides AB (publ) from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.08 | -34.42% |
| 2025 | $-0.12 | -23.10% |
| 2024 | $-0.16 | -20.23% |
| 2023 | $-0.19 | -50.71% |
| 2022 | $-0.39 | -81.22% |
| 2021 | $-2.10 | -32.15% |
| 2020 | $-3.09 | 101.56% |
| 2019 | $-1.54 | 40.37% |
| 2018 | $-1.09 | 39.94% |
| 2017 | $-0.78 | 140.68% |
| 2016 | $-0.32 | 99.94% |
| 2015 | $-0.16 | 49.13% |
| 2014 | $-0.11 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -19,998.35% |
US
|
|
| $-7.07 | 8,883.48% |
US
|
|
| $-5.29 | 6,621.73% |
AU
|
|
| $12.88 | -16,466.07% |
BE
|
|
| $21.56 | -27,495.17% |
NL
|
Questions about Oncopeptides AB (publ)'s earnings per share (EPS)
What is Oncopeptides AB (publ)'s earnings per share (EPS)?
Oncopeptides AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.08, as of Jun 2026.
What was Oncopeptides AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Oncopeptides AB (publ)'s earnings per share (EPS) was $-0.12, compared with $-0.16 in 2024.
How has Oncopeptides AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Oncopeptides AB (publ)'s earnings per share (EPS) was highest in 2025 ($-0.12) and lowest in 2020 ($-3.09).
How does Oncopeptides AB (publ)'s earnings per share (EPS) compare with similar companies?
Oncopeptides AB (publ)'s earnings per share (EPS) ($-0.08) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.